Print Page

Medicine recalls

 
Canada: Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
 
Health Canada announces that Sandoz Canada Incorporated is recalling 3 lots of Sandoz Fesoterodine Fumarate 8 mg tablet (extended-release) (lot number: 2205009088, 2205010476 and 2205011235) from retailers because the diester impurity is out of specification in the affected lots.

Please refer to the following website in Health Canada for details: http://recalls-rappels.canada.ca/en/alert-recall/sandoz-fesoterodine-fumarate-8-mg-tablet-out-specification-diester-impurity

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Friday, May 17, 2024
Issued at HKT 16:15
 
Related Information:
Canada: Recall: Sandoz Fesoterodine Fumarate 8 mg tablet; Out of specification (... Posted 2025-03-22
Canada: Recall: SANDOZ FESOTERODINE FUMARATE: The Diester impurity is out of spe... Posted 2024-12-10
 
back